AI assistant
Lasa Supergenerics Limited — Call Transcript 2020
Jun 18, 2020
61953_rns_2020-06-18_e71981ab-103a-43d7-ab40-afe2f2006288.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [131 x 76] intentionally omitted <==
Lasa Supergenerics Limited Q4 & FY20 Earnings Conference Call
Friday, 19[th] June 2020 at 05:30 p.m.
Thursday, 18[th] June 2020 : Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the fourth quarter and Financial Year ended March 31st, 2020.
It will organize an earnings conference call for analysts on Friday, 19th June 2020 @ 05:30 p.m to discuss the Company’s Q4 & FY20 financial performance.
Dr. Omkar Herlekar - Chairperson & Managing Director will represent LASA Supergenerics Limited on the call.
The financial results are available on the corporate website – www.lasalabs.com and website of exchanges www.bseindia.com & www.nseindia.com
DETAILS OF THE CONFERENCE CALL
==> picture [470 x 180] intentionally omitted <==
----- Start of picture text ----- Timing 5:30p.m. IST on Friday,19 [th] June, 2020Conference dial-in Primary number +91 22 6280 1341 / +91 22 7115 8242Local Access Number +91-7045671221Hong Kong Local Access Number 800964448Singapore Local Access Number 8001012045UK Local Access Number 08081011573USA Local Access Number 18667462133----- End of picture text -----
About Lasa Supergenerics Limited (www.lasalabs.com/; BSE: 540702; NSE: LASA)
Incorporated in 2011, Lasa Supergenerics Limited is a globally well trusted brand with high quality products, accepted by large companies across the globe. Our Company is the pioneer and amongst the leading players in the manufacturing of Veterinary APIs, with a well-established brand known for its high-quality products amongst various customers. The Company has its unit with state of art manufacturing facilities located at Mahad & Chiplun, Maharashtra with a total installed capacity of 4,300 MT. The Company has over 25% of APIs exported to counties like Australia, Bangladesh, Middle East, China, Turkey, Egypt, Jordan, Korea, Pakistan etc.
For more information contact:
Mr. Hitesh Wadhwani Mr. Gaurav Girdhar Lasa Supergenerics Ltd. Concept Investor Relations Tel: 7798888147 Tel: +022 40558934 E-mail: [email protected] M: +91 7798232425 Email:[email protected]